With a multi faceted approach, Pharmagen, Inc. is meeting the demands of the health provider market through dynamic, independent wholesale, compounding/admix, and innovative IT solutions. Nationally focused, we are a distributor of specialty drugs, compounding and admix pharmacy and producer of over the counter OTC branded multivitamins to the healthcare provider market. The Food and Drug Administration continues to see an increasing number of shortages, especially those involving sterile injectable drugs. We currently function as a total solution provider to hospitals through sterile compounding/admix pharmacy and just in time source of supply of products that are hard to find due to drug manufacturers production shortages. Leveraging our understanding of drug shortages, our long term goal is to become an FDA approved manufacturer of habitually short supply, sterile pharmaceuticals. Through an industry changing, cGMP process, utilizing single use, modular systems, we intend to be the gold standard of sterile production in the United States. lt br / gt lt br / gt In addition to pharmaceuticals, we manufacture and distribute over the counter OTC branded health supplements. Our innovative approach to OTC is to create suites of products that are designed to work in conjunction with prescription medications to alleviate side effects and/or prevent drug interactions. With an aging population, more Americans than ever are on prescription medications and dangerous drug interactions are a growing problem. We are currently analyzing several OTC products that would allow us to become a powerful OTC player in the multi billon dollar health supplement market.
Quote | Pharmagen Inc (OTCMKTS:PHRX)
Last: | $1e-06 |
---|---|
Change Percent: | 0.0% |
Open: | $1e-06 |
Close: | $1e-06 |
High: | $1e-06 |
Low: | $1e-06 |
Volume: | 3,250 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Pharmagen Inc (OTCMKTS:PHRX)
Toronto, Ontario--(Newsfile Corp. - March 13, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC PINK: LMLLF) (" PharmaDrug " or the " Company "), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances, natural medicines, and previously approv...
Toronto, Ontario--(Newsfile Corp. - February 27, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (" PharmaDrug " or the " Company "), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychede...
Message Board Posts | Pharmagen Inc (OTCMKTS:PHRX)
Subject | By | Source | When |
---|---|---|---|
Activity today. EOM. | potofgold | investorshub | 01/11/2023 7:24:22 PM |
Activity today.com. | potofgold | investorshub | 01/04/2023 5:10:32 PM |
Activity today. EOM. | potofgold | investorshub | 12/30/2022 8:41:21 PM |
Activity today. EOM. | potofgold | investorshub | 12/29/2022 5:56:31 PM |
Activity today. EOM. | potofgold | investorshub | 12/28/2022 10:49:58 PM |
News, Short Squeeze, Breakout and More Instantly...
Toronto, Ontario--(Newsfile Corp. - March 13, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC PINK: LMLLF) (" PharmaDrug " or the " Company "), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances, natural medicines, and previously approv...
Toronto, Ontario--(Newsfile Corp. - February 27, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (" PharmaDrug " or the " Company "), a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychede...
Company to pursue regulatory filing for Phase I/II clinical study Toronto, Ontario--(Newsfile Corp. - February 14, 2024) - PharmaDrug Inc. (CSE: PHRX) (OTC Pink: LMLLF) (" PharmaDrug " or the " Company "), a specialty pharmaceutical company focused on the research, development and commercializat...